How Triple-Combination Gel Impacts Acne Bacteria
A fixed-dose, triple-combination gel containing clindamycin phosphate 1.2%, adapalene 0.15%, and benzoyl peroxide 3.1%—marketed as Cabtreo—significantly reduces biofilm formation and porphyrin production in clinical Cutibacterium acnes isolates. According to research presented at the 2026 American Academy of Dermatology Annual Meeting, these findings suggest the therapy targets bacterial virulence beyond simple antibacterial action.
What Are the Mechanisms Behind Cabtreo’s Efficacy?
Acne vulgaris often involves C. acnes, a commensal bacterium that can transition into a pathogen by forming biofilms and producing virulence factors. These mechanisms frequently lead to increased inflammation and bacterial adaptation, which can make the condition resistant to standard treatments.
Investigators tested 18 clinical C. acnes isolates to determine if Cabtreo could disrupt these specific pathways. When researchers exposed these isolates to the gel at concentrations five and 10 times the minimum inhibitory concentration (MIC), they observed a measurable decline in virulence factor expression.
While the triple-combination gel successfully reduced biofilm and porphyrins, the study found it did not affect lipase activity or lipase gene expression in any of the tested samples.
How Does the Gel Affect Biofilms and Porphyrins?
The impact on bacterial structures was confirmed through confocal imaging. The study showed that Cabtreo exposure resulted in weaker fluorescence signals and thinner biofilm structures compared to untreated control groups across all 18 tested isolates.
Porphyrin production, a key contributor to acne-related inflammation, also saw a sharp decline. Data presented at the meeting indicated that the gel reduced porphyrin levels by 64% at five times the MIC and by 80% at 10 times the MIC. These results indicate that the formulation may provide a multi-faceted approach to managing the skin environment during an acne breakout.
What Is the Future of Acne Treatment Research?
The current findings are limited to in vitro laboratory analyses, meaning the next phase of research will focus on clinical outcomes. While the reduction of virulence factors in a lab setting is a positive indicator, scientists must now determine if these effects translate into visible improvements for patients using the product in real-world scenarios.
Future studies will likely examine whether this reduction in biofilm and porphyrin production correlates with faster healing times or reduced recurrence rates for those suffering from chronic acne.
Frequently Asked Questions
- What is the primary function of the triple-combination gel? It combines clindamycin, adapalene, and benzoyl peroxide to inhibit bacterial growth and reduce virulence factors like biofilms and porphyrins.
- Did the study show the gel stops all bacterial activity? Not entirely. While it reduced biofilm and porphyrins, researchers found no significant effect on lipase activity or gene expression.
- Are these results applicable to human patients yet? The current data is based on laboratory (in vitro) studies. Further clinical trials are required to confirm these results in human patients.
When discussing acne treatments with a dermatologist, ask about the difference between antibacterial effects and the disruption of bacterial biofilms, as the latter can be a major factor in treatment-resistant cases.
Are you interested in learning more about the latest advancements in dermatological research? Subscribe to our newsletter for updates on clinical study findings and skincare science delivered directly to your inbox.
